Cellima Talks III
AI Tools in early pharmaceutical research
Join us for an exciting discussion on the use of specialized AI tools in early drug discovery.
Together with David Egan, CEO of Core Life Analytics, and Philipp Kainz, CEO of KML Vision, Stefan Prechtl discusses the use of the latest developments in the field of advanced machine learning and deep learning, which can significantly improve research efforts in early drug discovery.
In addition to all the opportunities and benefits of these modern technologies, the panelists also talk about the exaggerated expectations, exaggerated fears, and drawbacks of this modern approach.
Learn how to get the most out of your data by safely using AI tools.
This is a recording of a live-streamed event. The audience was able to ask questions in the chat during the interview, which were answered directly by the panelists.
